Sporotrichosis

Rex JH, Okhuysen PC. Sporothrix schenckii. In Bennett JE, Dolin R, Blaser MJ, eds. Principles and practice of infectious diseases. 9th ed. Philadelphia, PA: Elsevier, 2020: 3131-6.

Orofino-Costa R, Macedo PM, Rodrigues AM, et al. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017 Sep-Oct;92(5):606-20.Full text  Abstract

Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Nov 15;45(10):1255-65.Full text  Abstract

Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. Am J Med. 1993 Sep;95(3):279-85. Abstract

1. Rex JH, Okhuysen PC. Sporothrix schenckii. In Bennett JE, Dolin R, Blaser MJ, eds. Principles and practice of infectious diseases. 9th ed. Philadelphia, PA: Elsevier, 2020: 3131-6.

2. Kauffman CA. Sporotrichosis. Clin Infect Dis. 1999 Aug;29(2):231-6. Abstract

3. Hernández-Castro R, Pinto-Almazán R, Arenas R, et al. Epidemiology of Clinical Sporotrichosis in the Americas in the Last Ten Years. J Fungi (Basel). 2022 May 30;8(6):588.Full text  Abstract

4. Appenzeller S, Amaral TN, Amstalden EM, et al. Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature. Clin Rheumatol. 2006 Nov;25(6):926-8. Abstract

5. Crout JE, Brewer NS, Tompkins RB. Sporotrichosis arthritis: clinical features in seven patients. Ann Intern Med. 1977 Mar;86(3):294-7. Abstract

6. Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore). 1986 May;65(3):143-53. Abstract

7. Silva-Vergara ML, Maneira FR, De Oliveira RM, et al. Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol. 2005 Mar;43(2):187-90. Abstract

8. Hardman S, Stephenson I, Jenkins DR, et al. Disseminated Sporothix schenckii in a patient with AIDS. J Infect. 2005 Oct;51(3):e73-7. Abstract

9. al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis. 1998 Jun;26(6):1403-6. Abstract

10. da Rosa AC, Scroferneker ML, Vettorato R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):451-9. Abstract

11. Pappas PG, Tellez I, Deep AE, et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis. 2000 Jan;30(1):65-70.Full text  Abstract

12. Lv S, Hu X, Liu Z, et al. Clinical Epidemiology of Sporotrichosis in Jilin Province, China (1990-2019): A Series of 4969 Cases. Infect Drug Resist. 2022;15:1753-65.Full text  Abstract

13. Orofino-Costa R, Macedo PM, Rodrigues AM, et al. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017 Sep-Oct;92(5):606-20.Full text  Abstract

14. Barros MB, Schubach Ade O, do Valle AC, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis. 2004 Feb 15;38(4):529-35.Full text  Abstract

15. Silva MB, Costa MM, Torres CC, et al. Urban sporotrichosis: a neglected epidemic in Rio de Janeiro, Brazil [in Portuguese]. Cad Saude Publica. 2012 Oct;28(10):1867-80. Abstract

16. Rudramurthy SM, Cano J, Chakrabarti A, et al. Sporothrix globosa: is the only described Sporothrix species causing human infections in India? 17th Congress of International Society for Human and Animal Mycology (ISHAM). Tokyo, Japan. 2009. Abstract #PP-06-58. Nihon Ishinkin Gakkai Zasshi. 2010;51 Suppl:435.Full text

17. Oliveira MM, Almeida-Paes R, Muniz MM, et al. Phenotypic and molecular identification of sporothrix isolates from an epidemic area of sporotrichosis in Brazil. Mycopathologia. 2011 Oct;172(4):257-67. Abstract

18. Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis. 1979 Apr;139(4):424-31. Abstract

19. Lückhoff A, Busse R. Refilling of endothelial calcium stores without bypassing the cytosol. FEBS Lett. 1990 Dec 10;276(1-2):108-10. Abstract

20. Romo-Lozano Y, Hernández-Hernández F, Salinas E. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Scand J Immunol. 2012 Jul;76(1):11-20. Abstract

21. Sassá MF, Ferreira LS, de Abreu Ribeiro LC, et al. Immune response against Sporothrix schenckii in TLR-4-deficient mice. Mycopathologia. 2012 Jul;174(1):21-30. Abstract

22. Li M, Chen Q, Sun J, et al. Inflammatory response of human keratinocytes triggered by Sporothrix schenckii via Toll-like receptor 2 and 4. J Dermatol Sci. 2012 Apr;66(1):80-2. Abstract

23. Plouffe JF Jr, Silva J Jr, Fekety R, et al. Cell-mediated immune responses in sporotrichosis. J Infect Dis. 1979 Feb;139(2):152-7. Abstract

24. Koga T, Duan H, Furue M. Immunohistochemical detection of interferon-gamma-producing cells in granuloma formation of sporotrichosis. Med Mycol. 2002 Apr;40(2):111-4. Abstract

25. Boehm D, Lynch JM, Hodges GR, et al. Case report. Disseminated sporotrichosis presenting as sarcoidosis: electron microscopic and immunologic studies. Am J Med Sci. 1982 Mar-Apr;283(2):71-8. Abstract

26. Mayorga R, Cáceres A, Toriello C, et al. Study of an endemic sporotrichosis zone in the Ayarza lake region of Guatemala [in Spanish]. Bol Oficina Sanit Panam. 1979 Jul;87(1):20-34. Abstract

27. Barros NM, Pessoa AS, Brotas AM. Systemic sporotrichosis in an alcoholic patient. An Bras Dermatol. 2020 May-Jun;95(3):376-8.Full text  Abstract

28. Moreira JA, Freitas DF, Lamas CC. The impact of sporotrichosis in HIV-infected patients: a systematic review. Infection. 2015 Jun;43(3):267-76. Abstract

29. Gottlieb GS, Lesser CF, Holmes KK, et al. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists. Clin Infect Dis. 2003 Sep 15;37(6):838-40.Full text  Abstract

30. Hajjeh R, McDonnell S, Reef S, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis. 1997 Aug;176(2):499-504. Abstract

31. Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med. 1993 Jun 1;118(11):883-8. Abstract

32. Marques ME, Coelho KI, Sotto MN, et al. Comparison between histochemical and immunohistochemical methods for diagnosis of sporotrichosis. J Clin Pathol. 1992 Dec;45(12):1089-93. Abstract

33. Hu S, Chung WH, Hung SI, et al. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J Clin Microbiol. 2003 Apr;41(4):1414-8.Full text  Abstract

34. Scott EN, Kaufman L, Brown AC, et al. Serologic studies in the diagnosis and management of meningitis due to Sporothrix schenckii. N Engl J Med. 1987 Oct 8;317(15):935-40. Abstract

35. Galhardo MC, Silva MT, Lima MA, et al. Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome. J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):696-9.Full text  Abstract

36. Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Nov 15;45(10):1255-65.Full text  Abstract

37. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. Am J Med. 1993 Sep;95(3):279-85. Abstract

38. Restrepo A, Robledo J, Gómez I, et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol. 1986 Apr;122(4):413-7. Abstract

39. Conti Díaz IA, Civila E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses. 1992 May-Jun;35(5-6):153-6. Abstract

40. de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaes de Oliveira R, et al. Treatment of cutaneous sporotrichosis with itraconazole - study of 645 patients. Clin Infect Dis. 2011 Jun 15;52(12):e200-6.Full text  Abstract

41. Cabezas C, Bustamante B, Holgado W, et al. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J. 1996 Apr;15(4):352-4. Abstract

42. Itoh M, Okamoto S, Kariya H. Survey of 200 cases of sporotrichosis. Dermatologica. 1986;172(4):209-13. Abstract

43. Estrada-Castañón R, Chávez-López G, Estrada-Chávez G, et al. Report of 73 cases of cutaneous sporotrichosis in Mexico. An Bras Dermatol. 2018 Nov/Dec;93(6):907-9.Full text  Abstract

44. Chapman SW, Pappas P, Kauffmann C, et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses. 2004 Feb;47(1-2):62-8. Abstract

45. Francesconi G, Francesconi do Valle AC, Passos SL, et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia. 2011 May;171(5):349-54. Abstract

46. Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis. 1996 Jan;22(1):46-50. Abstract

47. Winn RE, Anderson J, Piper J, et al. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis. 1993 Aug;17(2):210-7. Abstract

48. Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128.Full text  Abstract

49. Hiruma M, Kawada A, Noguchi H, et al. Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses. 1992 Nov-Dec;35(11-12):293-9. Abstract

50. Hiruma M, Kagawa S. Effects of hyperthermia on phagocytosis and intracellular killing of Sporothrix schenckii by polymorphonuclear leukocytes. Mycopathologia. 1986 Aug;95(2):93-100. Abstract

51. Hata M, Tatsuno K, Suzuki Y, et al. Successful treatment of sporotrichosis with voriconazole. 17th Congress of International Society for Human and Animal Mycology (ISHAM). Tokyo, Japan. 2009. Abstract #PP-03-12. Nihon Ishinkin Gakkai Zasshi. 2010;51 Suppl:342.Full text

52. Fernández-Silva F, Capilla J, Mayayo E, et al. Efficacy of posaconazole in murine experimental sporotrichosis. Antimicrob Agents Chemother. 2012 May;56(5):2273-7. Abstract

53. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol. 1998 Oct;36(10):2950-6. Abstract

54. Fichman V, do Valle ACF, Freitas DFS, et al. Cryosurgery for the treatment of cutaneous sporotrichosis: experience with 199 cases. Br J Dermatol. 2018 Dec 18 [Epub ahead of print]. Abstract

55. Deray G. Amphotericin-B nephrotoxicity. J Antimicrob Chemother. 2002 Feb;49 Suppl 1:37-41. Abstract